Gil Schwartzberg - 31 Dec 2021 Form 5 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director, 10%+ Owner
Signature
/s/ Gil Schwartzberg
Issuer symbol
LIXT
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
14 Feb 2022, 19:48:25 UTC
Previous filing
02 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIXT Common Stock Gift $0 -15,000 -6.1% $0.000000 232,775 03 Aug 2021 Direct F1, F2
transaction LIXT Common Stock Gift $0 -10,000 -4.3% $0.000000 222,775 17 Aug 2021 Direct F1, F2
transaction LIXT Common Stock Gift $0 -7,000 -3.1% $0.000000 215,775 03 Sep 2021 Direct F1, F2
holding LIXT Common Stock 106,352 31 Dec 2021 By Continuum Partners, L.P.
holding LIXT Common Stock 186,667 31 Dec 2021 By Julie Schwartzberg Trust
holding LIXT Common Stock 375,926 31 Dec 2021 By Gil & Debbie Schwartzberg Family Trust, Gil Schwartzberg Separate Property
holding LIXT Common Stock 191,667 31 Dec 2021 By David N. Sterling Trust
holding LIXT Common Stock 16,667 31 Dec 2021 By Savannah Sterling Trust
holding LIXT Common Stock 16,667 31 Dec 2021 By Amanda Sterling Trust
holding LIXT Common Stock 16,667 31 Dec 2021 By Daniel Sterling Trust
holding LIXT Common Stock 16,667 31 Dec 2021 By Charles Sterling Trust
holding LIXT Common Stock 33,333 31 Dec 2021 By Julie Forman 2013 Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Donation to charity.
F2 The shares do not include derivative securities of the Reporting Person that have been reported on the Reporting Person's Forms 3 and 4.